Japan Tissue Engineering Management

Management Kriterienprüfungen 1/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Ken-Ichiro Hata

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	7yrs
Eigentum des Geschäftsführers	0.07%
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	7.4yrs

Jüngste Management Updates

Recent updates

Little Excitement Around Japan Tissue Engineering Co., Ltd.'s (TSE:7774) Revenues

Aug 01

The Market Lifts Japan Tissue Engineering Co., Ltd. (TSE:7774) Shares 35% But It Can Do More

Mar 06

We Think Japan Tissue Engineering (TYO:7774) Can Afford To Drive Business Growth

Feb 02

Geschäftsführer

Ken-Ichiro Hata (60 yo)

7yrs

Amtszeit

Mr. Ken-Ichiro Hata, D.D.S., Ph D., has been the Chief Executive Officer of Japan Tissue Engineering Co., Ltd. since November 3, 2017 and serves as its President since February 2021 and served as its Presi...

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Ken-Ichiro Hata	President	9.4yrs	keine Daten	0.073% ¥ 14.7m
Toshihiro Osuka	Senior Managing Executive Officer & Director	9.4yrs	keine Daten	0.24% ¥ 47.5m
Kiyotaka Kurahashi	Audit & Supervisory Board Member	7.4yrs	keine Daten	keine Daten
Takahiro Kato	Audit & Supervisory Board Member	16.4yrs	keine Daten	0.0074% ¥ 1.5m
Kaoru Ogawa	Audit & Supervisory Board Member	7.4yrs	keine Daten	keine Daten
Takayuki Nakano	Non-Executive Director	3.4yrs	keine Daten	keine Daten
Toshiyuki Masai	Independent Outside Non-Executive Director	2.5yrs	keine Daten	keine Daten
Hirotsugu Higashiyama	Non-Executive Director	1.4yrs	keine Daten	keine Daten
Yasuo Kitajima	Independent Outside Non-Executive Director	1.4yrs	keine Daten	keine Daten

7.4yrs

Durchschnittliche Betriebszugehörigkeit

66yo

Durchschnittliches Alter

Erfahrener Vorstand: 7774Die Vorstandsmitglieder gelten als erfahren (7.4 Jahre durchschnittliche Amtszeit).

Japan Tissue Engineering Management

Management Kriterienprüfungen 1/4

Wichtige Informationen

Jüngste Management Updates

No independent directors

No independent directors

Recent updates

Second quarter 2025 earnings released: JP¥0.34 loss per share (vs JP¥0.59 loss in 2Q 2024)

Japan Tissue Engineering Co., Ltd. to Report Q2, 2025 Results on Oct 31, 2024

First quarter 2025 earnings released: JP¥5.20 loss per share (vs JP¥0.32 profit in 1Q 2024)

Little Excitement Around Japan Tissue Engineering Co., Ltd.'s (TSE:7774) Revenues

Full year 2024 earnings released: EPS: JP¥3.52 (vs JP¥17.95 loss in FY 2023)

Full year 2024 earnings released: EPS: JP¥3.52 (vs JP¥17.95 loss in FY 2023)

New major risk - Share price stability

New minor risk - Share price stability

The Market Lifts Japan Tissue Engineering Co., Ltd. (TSE:7774) Shares 35% But It Can Do More

Japan Tissue Engineering Co., Ltd. to Report Fiscal Year 2024 Results on Apr 30, 2024

Third quarter 2024 earnings released: JP¥1.03 loss per share (vs JP¥5.02 loss in 3Q 2023)

Japan Tissue Engineering Co., Ltd. to Report Q3, 2024 Results on Jan 30, 2024

Second quarter 2024 earnings released: JP¥0.59 loss per share (vs JP¥3.77 loss in 2Q 2023)

Japan Tissue Engineering Co., Ltd. to Report Q2, 2024 Results on Oct 31, 2023

First quarter 2024 earnings released: EPS: JP¥0.32 (vs JP¥6.60 loss in 1Q 2023)

New major risk - Share price stability

Full year 2023 earnings released: JP¥17.95 loss per share (vs JP¥12.24 loss in FY 2022)

Japan Tissue Engineering Co., Ltd. to Report Q1, 2024 Results on Jul 31, 2023

Full year 2023 earnings released: JP¥17.95 loss per share (vs JP¥12.24 loss in FY 2022)

Third quarter 2023 earnings released: JP¥5.03 loss per share (vs JP¥1.80 loss in 3Q 2022)

Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2023

Japan Tissue Engineering Co., Ltd. to Report Q3, 2023 Results on Jan 31, 2023

No independent directors

Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2023

Second quarter 2023 earnings released

Japan Tissue Engineering Co., Ltd. to Report Q2, 2023 Results on Oct 31, 2022

First quarter 2023 earnings released

Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2023

Price target decreased to JP¥1,200

Full year 2022 earnings released: JP¥12.26 loss per share (vs JP¥11.48 loss in FY 2021)

Japan Tissue Engineering Co., Ltd. to Report Q1, 2023 Results on Jul 27, 2022

Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2023

Full year 2022 earnings released

No independent directors

Japan Tissue Engineering Co., Ltd. to Report Fiscal Year 2022 Results on Apr 26, 2022

Third quarter 2022 earnings: Revenues in line with analyst expectations

Japan Tissue Engineering Co., Ltd. Announces Earnings Guidance for the Fiscal Year Ending March 31, 2022

Japan Tissue Engineering Co., Ltd. Announces Start of Clinical Trial for Allogeneic Cultured Epidermis

Second quarter 2022 earnings released: JP¥3.40 loss per share (vs JP¥2.41 loss in 2Q 2021)

Japan Tissue Engineering Co., Ltd. Announces Approval of Autologous Cultured Oral Mucosal Epithelium Ocural for NHI Listing

First quarter 2022 earnings released

Japan Tissue Engineering Co., Ltd. Announces Approval Obtained for Autologous Cultured Oral Mucosal Epithelium “Ocural”

Japan Tissue Engineering Co., Ltd. Announces Marketing Approval of Autologous Cultured Oral Mucosal Epithelial Cell Sheet

Full year 2021 earnings released: JP¥11.48 loss per share (vs JP¥7.07 loss in FY 2020)

Teijin Limited (TSE:3401) completed the acquisition of 57.7% stake in Japan Tissue Engineering Co., Ltd. (JASDAQ:7774) from Fujifilm Corporation for ¥19.2 billion

New 90-day high: JP¥802

We Think Japan Tissue Engineering (TYO:7774) Can Afford To Drive Business Growth

Third quarter 2021 earnings released: JP¥3.40 loss per share (vs JP¥2.24 loss in 3Q 2020)

New 90-day high: JP¥739

Teijin Limited (TSE:3401) signed an agreement to acquire a 50.1% stake in Japan Tissue Engineering Co., Ltd. (JASDAQ:7774) from Fujifilm Corporation for ¥16.7 billion.

Japan Tissue Engineering Co., Ltd. to Report Q3, 2021 Results on Jan 29, 2021

First half earnings released

Japan Tissue Engineering Co., Ltd. to Report Q2, 2021 Results on Oct 30, 2020

Japan Tissue Engineering Co., Ltd. Do Not Provides Earnings Guidance for the Fiscal Year Ending March 31, 2021

New 90-day low - JP¥634

Japan Tissue Engineering Co., Ltd. to Report Q1, 2021 Results on Jul 30, 2020

Geschäftsführer

Amtszeit

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter